metformin has been researched along with Affective Disorders, Psychotic in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Affective Disorders, Psychotic: Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metabolic syndrome is prevalent in older adults and increases the risk of cardiovascular disease." | 2.45 | Metabolic risks in older adults receiving second-generation antipsychotic medication. ( Brooks, JO; Chang, HS; Krasnykh, O, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, JO | 1 |
| Chang, HS | 1 |
| Krasnykh, O | 1 |
1 review available for metformin and Affective Disorders, Psychotic
| Article | Year |
|---|---|
Metabolic risks in older adults receiving second-generation antipsychotic medication.
Topics: Affective Disorders, Psychotic; Aged; Aged, 80 and over; Antipsychotic Agents; Cardiovascular Diseas | 2009 |